Advertisement

Ricerca in clinica e in laboratorio

, Volume 16, Issue 4, pp 539–542 | Cite as

Thromboxane production in diabetes mellitus

  • Lorenzo Altomonte
  • Angelo Zoli
  • Alessandra Mangia
  • Giovanni Ghirlanda
  • Raffaele Manna
  • Aldo Bertoli
  • Aldo Virgilio Greco
Original Contributions
  • 18 Downloads

Summary

A correlation between increased platelet adhesiveness and aggregation and the development of angiopathy in diabetes mellitus can be made. Thromboxane produced by platelets represents a potent platelet aggregation factor. We studied the platelet TXB2 production during blood coagulation in carefully selected patients with type II diabetes mellitus in good metabolic control and the results were correlated with the presence or absence of microangiopathy, fasting blood glucose levels, type of therapy, age, duration of diabetes and the most important hematochemical parameters. No statistically significant differences were found between serum TXB2 concentrations in diabetic patients and control subjects, in diabetics with or without microangiopathy and in diabetics on insulin therapy or on oral hypoglycemic agents. We did not observe any correlation between TXB2 production and age, duration of diabetes, sex, basal blood glucose levels, total and HDL-cholesterol, triglycerides, blood creatinine and blood electrolytes. The thromboxane production may be a not important factor for determining the increased platelet aggregation which is at the origin of the angiopathy in diabetes mellitus.

Key-words

Diabetes mellitus Microangiopathy Platelets Thromboxane 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Bensoussan D., Levy Toledano S., Passa P., Caen J., Canivet J.: Platelet hyperaggregation and increased plasma level of von Willebrand factor in diabetes with retinopathy — Diabetologia11, 307, 1975.PubMedCrossRefGoogle Scholar
  2. 2.
    Bern M. M.: Platelet functions in diabetes mellitus — Diabetes27, 342, 1978.PubMedGoogle Scholar
  3. 3.
    Best L., Jones P. B. B., Preston F. E.: Effect of glucose on platelet thromboxane biosynthesis — Lancetii, 790, 1979.CrossRefGoogle Scholar
  4. 4.
    Butkus A., Skrinska V. A., Schumaker O. P.: Thromboxane production and platelet aggregation in diabetic subjects with clinical complications — Thrombos. Res.19, 211, 1980.CrossRefGoogle Scholar
  5. 5.
    Cerbone A. M., Cirillo F., Pannain M., Riccardi G., Rivellese A., Di Mimmo G., Mancini M.: Ruolo delle prostaglandine e del trombossano nell’aumentato legame del fibrinogeno alle piastrine di pazienti diabetici — G. Diabetol.4, 301, 1984.Google Scholar
  6. 6.
    Colwell J. A., Halushka P. V., Sarji K., Levine J., Sagel J., Nair R. G.: Altered platelet function in diabetes mellitus — Diabetes25 (Suppl. 2), 826, 1976.PubMedGoogle Scholar
  7. 7.
    Colwell J. A., Halushka P. V., Sarji K., Sagel J.: Platelet function and diabetes mellitus — Med. Clin. N. Amer.62, 753, 1978.PubMedGoogle Scholar
  8. 8.
    D’Angelo A., Micossi P., Mannucci P. M., Garimberti B., Franchi F., Pozza G.: Increased production of platelet thromboxane B2 in non insulin-dependent diabetes. Relationship to vascular complications — Europ. J. clin. Invest.14, 83, 1984.PubMedCrossRefGoogle Scholar
  9. 9.
    Davì G., Rini G. B., Averna M., Novo S., Di Fede G., Pinto A., Notarbartolo A., Strano A.: Thromboxane B2 formation and platelet sensitivity to prostacyclin in insulin-dependent and insulin-independent diabetics — Thrombos. Res.26, 359, 1982.CrossRefGoogle Scholar
  10. 10.
    Davis T. M. E., Mitchell M. D., Turner R. C.: Prostacyclin and thromboxane metabolites in diabetes — Lancetii, 270, 1979.Google Scholar
  11. 11.
    Ganda O. M. P.: Pathogenesis of microvascular disease in the human diabetics — Diabetes29, 931, 1980.PubMedGoogle Scholar
  12. 12.
    Halushka P. V., Rogers R. C., Loadholt C. B., Colwell J. A.: Increased platelet thromboxane synthesis in diabetes mellitus — J. Lab. clin. Med.97, 87, 1981.PubMedGoogle Scholar
  13. 13.
    Halushka P. V., Rogers R. C., Loadholt C. B., Wohltman H., Mayfield R., McCoy S., Colwell J. A.: Increased platelet prostaglandin and thromboxane synthesis in diabetes mellitus — Hormone metabol. Res.11 (Suppl. 1), 7, 1981.Google Scholar
  14. 14.
    Heath H., Bridgen W. D., Cavener J. V., Pollock J., Hunter P. R., Kesley J. P., Bloom A.: Platelet adhesiveness and aggregation in relation to diabetic retinopathy — Diabetologia7, 308, 1971.PubMedCrossRefGoogle Scholar
  15. 15.
    Kwaan H. C., Colwell J. A., Cruz S., Suwawela N., Bobbie J. G.: Increased platelet aggregation in diabetes mellitus — J. Lab. clin. Med.80, 236, 1972.PubMedGoogle Scholar
  16. 16.
    Lagarde M., Burtin M., Berciaud P., Blanc M., Velardo B., Dechavanne M.: Increased platelet thromboxane A2 formation and its plasmatic half-life in diabetes mellitus — Thrombos. Res.19, 823, 1980.CrossRefGoogle Scholar
  17. 17.
    McDonald J. W. D., Duprè J., Rodger N. W., Champion M. C., Webb C. D., Ali M.: Comparison of platelet thromboxane synthesis in diabetic patients on conventional insulin therapy and continuous insulin infusions — Thrombos. Res.28, 705, 1982.CrossRefGoogle Scholar
  18. 18.
    Sagel J., Colwell J. A., Crook L., Laimins M.: Increased platelet aggregation in early diabetes mellitus — Ann. intern. Med.82, 733, 1975.PubMedGoogle Scholar
  19. 19.
    Samuelsson B., Hamberg M., Malmstem C., Svensson J.: Prostaglandin endoperoxides and thromboxanes in platelet aggregation. In:Samuelsson B., Paoletti R. (Eds): Advances in prostaglandin and thromboxane research. Raven Press, New York, 1976; p. 763.Google Scholar
  20. 20.
    Szirtes M.: Platelet aggregation in diabetes mellitus — Advanc. Cardiol.4, 179, 1970.Google Scholar
  21. 21.
    Triolo G., Davì G., Giardina E., Cardella F., Meli A., La Grutta A., Strano A., Bompiani G. D.: Circulating immune complexes and platelet thromboxane synthesis in patients with insulin-dependent (type I) diabetes mellitus — Diabetes33, 728, 1984.PubMedCrossRefGoogle Scholar
  22. 22.
    Ylikorkala O., Kaila J., Viinika L.: Prostacyclin and thromboxane in diabetes — Brit. med. J.283, 1148, 1981.CrossRefGoogle Scholar
  23. 23.
    Ziboh V. A., Maruta M., Lord J., Lagle W. D., Lucky W.: Increased biosynthesis of thromboxane A2 by diabetic platelets — Europ. J. clin. Invest.9, 223, 1979.PubMedCrossRefGoogle Scholar

Copyright information

© Casa Editrice «Il Ponte» 1986

Authors and Affiliations

  • Lorenzo Altomonte
    • 1
  • Angelo Zoli
    • 1
  • Alessandra Mangia
    • 1
  • Giovanni Ghirlanda
    • 1
  • Raffaele Manna
    • 1
  • Aldo Bertoli
    • 1
  • Aldo Virgilio Greco
    • 1
  1. 1.Istituto di Clinica Medica Generale e Terapia MedicaUniversità Cattolica del Sacro CuoreRomaItalia

Personalised recommendations